Cerus (CERS) Competitors $1.33 -0.03 (-2.21%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$1.32 -0.01 (-0.38%) As of 04/15/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. STAA, OSUR, ANIK, UTMD, COO, WST, ALGN, MMSI, ICUI, and HAEShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. Cerus vs. STAAR Surgical OraSure Technologies Anika Therapeutics Utah Medical Products Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics Cerus (NASDAQ:CERS) and STAAR Surgical (NASDAQ:STAA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk. Is CERS or STAA more profitable? STAAR Surgical has a net margin of -6.44% compared to Cerus' net margin of -11.60%. STAAR Surgical's return on equity of -3.35% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-11.60% -40.55% -11.12% STAAR Surgical -6.44%-3.35%-2.67% Does the media prefer CERS or STAA? In the previous week, STAAR Surgical had 11 more articles in the media than Cerus. MarketBeat recorded 14 mentions for STAAR Surgical and 3 mentions for Cerus. Cerus' average media sentiment score of 1.44 beat STAAR Surgical's score of 1.09 indicating that Cerus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cerus 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 7 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor CERS or STAA? Cerus received 281 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 54.22% of users gave STAAR Surgical an outperform vote. CompanyUnderperformOutperformCerusOutperform Votes57072.34% Underperform Votes21827.66% STAAR SurgicalOutperform Votes28954.22% Underperform Votes24445.78% Which has preferable valuation and earnings, CERS or STAA? STAAR Surgical has higher revenue and earnings than Cerus. STAAR Surgical is trading at a lower price-to-earnings ratio than Cerus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$180.27M1.37-$37.49M-$0.11-12.09STAAR Surgical$313.90M2.60-$20.21M-$0.41-40.29 Do insiders and institutionals have more ownership in CERS or STAA? 78.4% of Cerus shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 3.4% of Cerus shares are held by insiders. Comparatively, 1.0% of STAAR Surgical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts rate CERS or STAA? Cerus presently has a consensus target price of $3.50, suggesting a potential upside of 163.16%. STAAR Surgical has a consensus target price of $25.29, suggesting a potential upside of 53.06%. Given Cerus' stronger consensus rating and higher possible upside, equities research analysts plainly believe Cerus is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00STAAR Surgical 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility and risk, CERS or STAA? Cerus has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. SummaryCerus beats STAAR Surgical on 10 of the 18 factors compared between the two stocks. Remove Ads Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$247.10M$4.07B$5.33B$7.57BDividend YieldN/A39.50%5.11%4.32%P/E Ratio-12.0927.6321.7317.81Price / Sales1.3750.20379.1994.60Price / CashN/A51.0838.1534.64Price / Book4.595.826.464.00Net Income-$37.49M$67.09M$3.20B$247.23M7 Day Performance9.02%5.64%6.54%7.26%1 Month Performance-8.28%-3.20%-8.55%-6.26%1 Year Performance-23.12%14.87%10.33%-0.18% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.5736 of 5 stars$1.33-2.2%$3.50+163.2%-23.1%$247.10M$180.27M-12.09290Gap DownSTAASTAAR Surgical4.2784 of 5 stars$16.14+1.4%$25.29+56.7%-64.3%$796.11M$313.90M-39.37960Positive NewsGap DownOSUROraSure Technologies4.6794 of 5 stars$3.01-3.2%$5.50+82.7%-45.8%$225.15M$185.83M20.07840News CoveragePositive NewsGap DownANIKAnika Therapeutics3.9906 of 5 stars$13.92-0.6%$22.00+58.0%-45.8%$197.33M$119.91M-2.09300Gap DownUTMDUtah Medical Products3.0333 of 5 stars$54.39-0.8%N/A-22.4%$178.51M$40.90M13.77180Upcoming EarningsNews CoveragePositive NewsCOOCooper Companies3.1142 of 5 stars$73.31-0.6%$110.25+50.4%-15.5%$14.66B$3.93B37.6016,000Positive NewsWSTWest Pharmaceutical Services4.5688 of 5 stars$201.28-0.9%$332.50+65.2%-43.9%$14.55B$2.89B30.0910,700Analyst RevisionALGNAlign Technology4.6582 of 5 stars$153.35-0.1%$262.64+71.3%-46.1%$11.23B$4.00B27.3421,610Analyst RevisionNews CoverageHigh Trading VolumeMMSIMerit Medical Systems4.4981 of 5 stars$92.51+0.0%$111.70+20.7%+27.8%$5.46B$1.36B45.356,950Short Interest ↓Positive NewsHigh Trading VolumeICUIICU Medical3.7976 of 5 stars$142.25+2.1%$168.67+18.6%+43.8%$3.49B$2.38B-31.1314,500Analyst UpgradePositive NewsGap DownHAEHaemonetics4.6195 of 5 stars$58.96-3.2%$101.22+71.7%-31.4%$2.96B$1.37B23.212,820Short Interest ↓Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies STAA Competitors OSUR Competitors ANIK Competitors UTMD Competitors COO Competitors WST Competitors ALGN Competitors MMSI Competitors ICUI Competitors HAE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
